New trial aims to fix blood vessel damage in african americans
NCT ID NCT04769206
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a drug called galantamine can improve blood vessel function and reduce harmful stress in the blood vessels of African Americans. Researchers will measure changes in blood flow and markers of cell damage over three months. The goal is to find a new way to prevent heart disease in this high-risk group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOTHELIAL DYSFUNCTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chaney Johnson
RECRUITINGNashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a pill shield the brain and kidneys during heart surgery?
- Tiny particles in blood may signal hidden heart risk in hypertensive children
- Ancient herb gotu kola put to the test for healthier arteries in aging
- Could cocoa and veggies protect against pregnancy complications?
- Fatty meal test reveals hidden clues about blood vessel health
- Hidden blood vessel damage may predict heart surgery complications